First-pass extracted concept

DNA nanotechnology

Candidate: concept label2 source documents3 linked claims

Jump to explainers Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Extracted Explainers

What the tool is doing

DNA nanotechnology is presented as a route to stimuli-responsive structures with molecular-level programmability. These structures can perform logical operations using complex biological inputs.

Source 1DOI PubMed

DNA nanotechnology is presented as a primary biomolecular architecture within smart drug delivery systems. The abstract highlights its unique design space.

Source 2DOI PubMed

What problem it solves

It helps implement programmable sensing and decision behavior at the molecular interface.

Source 1DOI PubMed

In the review framing, it contributes programmable architecture options for responsive delivery design.

Source 2DOI PubMed

Alternatives

The abstract places DNA nanotechnology alongside peptide/protein-based systems and polysaccharide-based systems as alternative architecture classes.

Source 2DOI PubMed

Evidence Snippets

DNA nanotechnology provides molecular-level programmability through stimuli-responsive structures that can perform logical operations based on complex biological inputs.

Evidence 1Source 1DOI PubMedprovenance

We then conduct an in-depth survey of the primary biomolecular architectures, examining the unique design space offered by DNA nanotechnology

Evidence 2Source 2DOI PubMedprovenance

Supporting Sources

Source 1primary paper2025MEDDOI PubMed

1 evidence snippet 2 linked claims Claim 1 Claim 2

Source 2primary paper2025MEDDOI PubMed

1 evidence snippet 1 linked claim Claim 1

Linked Claims

Claim 1architecture overviewsupports2025Source 2DOI PubMed

Primary biomolecular architectures discussed for smart drug delivery include DNA nanotechnology, peptide and protein systems, and polysaccharide systems.

Claim 2enables closed loop theranosticssupports2025Source 1DOI PubMed

Converging technologies in synthetic biology, DNA nanotechnology, artificial intelligence, metabolic engineering, and advanced manufacturing are enabling autonomous theranostic systems with closed-loop functionality that sense biological parameters, process information through molecular computing, and adjust therapeutic activity accordingly.

Claim 3provides programmabilitysupports2025Source 1DOI PubMed

DNA nanotechnology provides molecular-level programmability through stimuli-responsive structures that can perform logical operations based on complex biological inputs.